FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385670146> ?p ?o ?g. }

• W4385670146 endingPage "S295" @default.
• W4385670146 startingPage "S294" @default.
• W4385670146 abstract "Introduction The kynurenine pathway of tryptophan catabolism has come into the spotlight of schizophrenia research since its catabolites exert neuroactive effects. A strong body of evidence suggests that kynurenic acid, a catabolite of kynurenine pathway, acts as the only endogenous NMDA receptor antagonist leading to the weakening of circuits in layer III of dorsolateral prefrontal cortex of schizophrenia patients. Studies exploring the levels of kynurenic acid and other metabolites of tryptophan in peripheral blood did not yield any definite conclusions. Objectives Primary objective of this study was to assess differences in concentrations of key constituents of kynurenic pathway in blood plasma – tryptophan (TRP), kynurenine (KYN) and kynurenic acid (KYNA) between schizophrenia patients (SCZ) and healthy controls (HC). Secondary objective was to explore correlations between these concentrations and clinical characteristics. Methods In our two-centre prospective case-control study we measured plasma concentrations of TRP, KYN and KYNA in 36 healthy controls (HC) and 38 schizophrenia (SCZ) patients during acute exacerbation and remission and explored the correlations with clinical parameters using PANSS scale. The patients were matched with HC by age, sex and body mass index and exclusion criteria included obesity class 2 or higher, any concomitant organic mental or neurological disorder, acute or chronic inflammatory disease, and use of immunomodulatory drugs or psychoactive substances. Results TRP concentrations were significantly higher in HC than in SCZ patients in acute phase (p<0,001) and remission (p<0,001), while SCZ patients in acute phase had significantly higher TRP levels than in remission (p<0,01). Levels of KYNA and KYN were significantly lower in SCZ patients than in HC both in acute phase and remission, all with high statistical significance (p<0,001). There was no statistically significant difference between acute phase and remission neither for KYN (p>0,05), nor for KYNA (p>0,05). There was no correlation of plasma levels of TRP, KYN and KYNA with total PANSS score, PANSS positive scale score, PANSS negative scale score and PANSS general psychopathology scores, both in acute phase and remission (p>0,05). Also, there was no correlation between plasma levels of TRP, KYN and KYNA in SCZ patients in remission with improvements measured with PANSS scale (p>0,05). Conclusions Although there are concerns about the value of measurement of metabolites of kynurenine pathway in the peripheral blood, our data suggest that significantly decreased levels of KYN and KYNA could suggest that disrupted TRP degradation in SCZ patients may be reflected in the peripheral blood as well. Further studies of peripheral levels of kynurenine pathway metabolites on larger samples should also explore effects of antipsychotic therapy, but also their correlation with other clinical parameters such as neurocognition. Disclosure of Interest None Declared" @default.
• W4385670146 created "2023-08-09" @default.
• W4385670146 creator A5000348530 @default.
• W4385670146 creator A5009189002 @default.
• W4385670146 creator A5019502076 @default.
• W4385670146 creator A5035507714 @default.
• W4385670146 creator A5040055018 @default.
• W4385670146 creator A5044648704 @default.
• W4385670146 creator A5055954620 @default.
• W4385670146 creator A5056255799 @default.
• W4385670146 creator A5077911119 @default.
• W4385670146 creator A5081571685 @default.
• W4385670146 creator A5092614882 @default.
• W4385670146 date "2023-03-01" @default.
• W4385670146 modified "2023-10-14" @default.
• W4385670146 title "Decreased plasma concentrations of kynurenine and kynurenic acid in schizophrenia patients" @default.
• W4385670146 doi "https://doi.org/10.1192/j.eurpsy.2023.658" @default.
• W4385670146 hasPublicationYear "2023" @default.
• W4385670146 type Work @default.
• W4385670146 citedByCount "0" @default.
• W4385670146 crossrefType "journal-article" @default.
• W4385670146 hasAuthorship W4385670146A5000348530 @default.
• W4385670146 hasAuthorship W4385670146A5009189002 @default.
• W4385670146 hasAuthorship W4385670146A5019502076 @default.
• W4385670146 hasAuthorship W4385670146A5035507714 @default.
• W4385670146 hasAuthorship W4385670146A5040055018 @default.
• W4385670146 hasAuthorship W4385670146A5044648704 @default.
• W4385670146 hasAuthorship W4385670146A5055954620 @default.
• W4385670146 hasAuthorship W4385670146A5056255799 @default.
• W4385670146 hasAuthorship W4385670146A5077911119 @default.
• W4385670146 hasAuthorship W4385670146A5081571685 @default.
• W4385670146 hasAuthorship W4385670146A5092614882 @default.
• W4385670146 hasBestOaLocation W43856701461 @default.
• W4385670146 hasConcept C118552586 @default.
• W4385670146 hasConcept C126322002 @default.
• W4385670146 hasConcept C134018914 @default.
• W4385670146 hasConcept C170493617 @default.
• W4385670146 hasConcept C185592680 @default.
• W4385670146 hasConcept C2776412080 @default.
• W4385670146 hasConcept C2776706248 @default.
• W4385670146 hasConcept C2776710720 @default.
• W4385670146 hasConcept C2776841986 @default.
• W4385670146 hasConcept C2777503454 @default.
• W4385670146 hasConcept C2777896816 @default.
• W4385670146 hasConcept C2779727114 @default.
• W4385670146 hasConcept C2780135775 @default.
• W4385670146 hasConcept C515207424 @default.
• W4385670146 hasConcept C55493867 @default.
• W4385670146 hasConcept C67018056 @default.
• W4385670146 hasConcept C71924100 @default.
• W4385670146 hasConcept C98274493 @default.
• W4385670146 hasConceptScore W4385670146C118552586 @default.
• W4385670146 hasConceptScore W4385670146C126322002 @default.
• W4385670146 hasConceptScore W4385670146C134018914 @default.
• W4385670146 hasConceptScore W4385670146C170493617 @default.
• W4385670146 hasConceptScore W4385670146C185592680 @default.
• W4385670146 hasConceptScore W4385670146C2776412080 @default.
• W4385670146 hasConceptScore W4385670146C2776706248 @default.
• W4385670146 hasConceptScore W4385670146C2776710720 @default.
• W4385670146 hasConceptScore W4385670146C2776841986 @default.
• W4385670146 hasConceptScore W4385670146C2777503454 @default.
• W4385670146 hasConceptScore W4385670146C2777896816 @default.
• W4385670146 hasConceptScore W4385670146C2779727114 @default.
• W4385670146 hasConceptScore W4385670146C2780135775 @default.
• W4385670146 hasConceptScore W4385670146C515207424 @default.
• W4385670146 hasConceptScore W4385670146C55493867 @default.
• W4385670146 hasConceptScore W4385670146C67018056 @default.
• W4385670146 hasConceptScore W4385670146C71924100 @default.
• W4385670146 hasConceptScore W4385670146C98274493 @default.
• W4385670146 hasIssue "S1" @default.
• W4385670146 hasLocation W43856701461 @default.
• W4385670146 hasOpenAccess W4385670146 @default.
• W4385670146 hasPrimaryLocation W43856701461 @default.
• W4385670146 hasRelatedWork W203081204 @default.
• W4385670146 hasRelatedWork W2061383340 @default.
• W4385670146 hasRelatedWork W2093220856 @default.
• W4385670146 hasRelatedWork W2188242390 @default.
• W4385670146 hasRelatedWork W2616077938 @default.
• W4385670146 hasRelatedWork W3022712936 @default.
• W4385670146 hasRelatedWork W4206597252 @default.
• W4385670146 hasRelatedWork W4212882642 @default.
• W4385670146 hasRelatedWork W4384830518 @default.
• W4385670146 hasRelatedWork W68102272 @default.
• W4385670146 hasVolume "66" @default.
• W4385670146 isParatext "false" @default.
• W4385670146 isRetracted "false" @default.
• W4385670146 workType "article" @default.